Box , Kampala, Uganda. The real value of such meetings lies in their ability to drive political commitments and provide a forum for leadership and global cooperation on key issues. Governments should follow the lead of South Africa in setting national targets for NCDs and using legislation to ensure those targets are met. No country can afford to wait until in the hope that the UN might include NCD targets in the successor framework to the Millennium Development Goals.
Targets endorsed in New York are far less likely to lead to change than those passed through a national parliament. National political champions should ensure the current targets being developed under the auspices of the World Health Organization have strong country ownership and are endorsed by parliaments in Second, we need to put increased focus on replicating and scaling up what works.
The Maternal and Child Health movement launched a global knowledge exchange in in order to share and replicate examples of successful programmes by governments and NGOs. There have been countless examples of successful programmes addressing NCDs and their risk factors since the UN Summit, but too often these success stories are never shared or given adequate visibility.
With the Summit now past and tight governments budgets a reality for the foreseeable future, global organizations working on NCDs should focus on collating and promoting successful and cost effective NCD programmes that can be replicated and scaled up. A starting point would be a series of publications containing NCD case studies from each major UN region highlighting successful prevention and treatment programmes.
Successful programs can be adapted, implemented and scaled up in a variety of settings, but these examples need to be easily accessible to busy policy makers and clinicians. Third, every country should explore opportunities to integrate NCD screening and treatment into communicable disease programmes to ensure a more patient centred approach to care.
Here in Uganda, health professionals have been leading from the frontlines and working tirelessly to improve the lives of those affected by NCDs. The UN Summit was a historical event and we know change will not come overnight, but we cannot wait any longer to take action.
Now is the time to use the momentum from the Summit and focus on country action and replicating and scaling up successful programmes.
Various factors determine adherence to therapy yet there is no data regarding current use of Benzapenin patients with RHD attending Mulago hospital.
The study aims were, 1 to determine the levels of adherence with Benzapen prophylaxis among Rheumatic heart disease patients in Mulago hospital and 2 to identify patient factors associated with adherence or non-adherence with Benzapen prophylaxis among RHD patients in Mulago hospital.
This was a longitudinal observational study carried out in Mulago Hospital cardiac clinics over a period of 10 months. Data on demographic characteristics and disease status was collected by means of a standardized questionnaire and a card to document the injections of Benzapen received.
Most participants were females 75 The age range was years, with a mean of The highest education level was primary school for most patients, 44 The mean adherence level was Factors Associated with adherence: Higher education status, residing near health facility favored high adherence, while painful injection was a major reason among poor performers.
Box , Kampala — Uganda. Adherence to penicillin prophylaxis is therefore essential to prevent rapid disease progress. Adherence variability to 3 or 4-weekly injections of benzathine penicillin is well documented both in the community setting and in hospital-based studies. Several factors could explain the non adherence observed among these patients: Issue 6 of rheumatic fever are not repeatedly reiterated.
Further, practitioners in the community might be reluctant to administer penicillin injections for fear of anaphylaxis. Therefore, the study aims were, to determine the level of adherence to benzathine penicillin prophylaxis among Rheumatic Heart Disease patients attending Mulago hospital, establish the patient factors associated with adherence and the reasons for missing monthly benzathine penicillin injections. We obtained informed consent for all the patients and informed assent for those unable to give consent.
This was a longitudinal observational study carried out in Mulago hospital, the national referral and Makerere University teaching hospital located in Kampala — Uganda, which receives more than patients with RHD annually.
New and Old RHD patients aged 5 — 55 years who were still eligible to continue prophylaxis for a period not less than one year from the time of recruitment and consented to the study were recruited. For those who refused to consent, a reason would be stated in the study book why they were not be enrolled.
In addition, data regarding the following was collected: